125 related articles for article (PubMed ID: 35914649)
21. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Deckert M; Reifenberger G; Wechsler W
J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
[TBL] [Abstract][Full Text] [Related]
22. Correlation of clinical features and telomerase activity in human gliomas.
Huang F; Kanno H; Yamamoto I; Lin Y; Kubota Y
J Neurooncol; 1999 Jun; 43(2):137-42. PubMed ID: 10533725
[TBL] [Abstract][Full Text] [Related]
23. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
24. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.
Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY
J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms.
Tugnoli V; Tosi MR; Barbarella G; Ricci R; Leonardi M; Calbucci F; Bertoluzza A
Oncol Rep; 1998; 5(5):1199-203. PubMed ID: 9683835
[TBL] [Abstract][Full Text] [Related]
26. Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors.
Barbosa M; Rios O; Velásquez M; Villalobos J; Ehrmanns J
Surg Neurol; 2001 Feb; 55(2):106-12. PubMed ID: 11301094
[TBL] [Abstract][Full Text] [Related]
27. Expression of cysteine protease inhibitors in human gliomas and meningiomas.
Sivaparvathi M; McCutcheon I; Sawaya R; Nicolson GL; Rao JS
Clin Exp Metastasis; 1996 Sep; 14(4):344-50. PubMed ID: 8878408
[TBL] [Abstract][Full Text] [Related]
28. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
29. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.
Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M
Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269
[TBL] [Abstract][Full Text] [Related]
31. Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues.
Ueba T; Takahashi JA; Fukumoto M; Ohta M; Ito N; Oda Y; Kikuchi H; Hatanaka M
Neurosurgery; 1994 Feb; 34(2):221-5; discussion 225-6. PubMed ID: 8177381
[TBL] [Abstract][Full Text] [Related]
32. Expression of Ki-67 and p53 in meningiomas.
Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
[TBL] [Abstract][Full Text] [Related]
33. Tumor infiltrating immune cells in gliomas and meningiomas.
Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
[TBL] [Abstract][Full Text] [Related]
34. Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin.
Utsuki S; Oka H; Sato Y; Kawano N; Tsuchiya B; Kobayashi I; Fujii K
Clin Neuropathol; 2005; 24(1):8-12. PubMed ID: 15696778
[TBL] [Abstract][Full Text] [Related]
35. Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas.
Kafadar AM; Ergen A; Zeybek U; Agachan B; Kuday C; Isbir T
Cell Biochem Funct; 2006; 24(5):455-60. PubMed ID: 16142697
[TBL] [Abstract][Full Text] [Related]
36. Fibronectin and sialic acid levels in human meningiomas and gliomas.
Sönmez H; Kökoğlu E; Süer S; Ozyurt E
Cancer Lett; 1995 Apr; 90(2):119-22. PubMed ID: 7736446
[TBL] [Abstract][Full Text] [Related]
37. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical study of extracellular matrices in human glioma and meningioma].
Wang L; Liang Y
Zhonghua Yi Xue Za Zhi; 1991 Feb; 71(2):81-3, 8. PubMed ID: 1647841
[TBL] [Abstract][Full Text] [Related]
39. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
